BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31187483)

  • 21. Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient.
    Reid K; Camacho-Vanegas O; Pandya D; Camacho SC; Qiao RF; Kalir T; Padron-Rhenals MM; Beddoe AM; Dottino P; Martignetti JA
    Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37848227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors.
    Yang HP; Meeker A; Guido R; Gunter MJ; Huang GS; Luhn P; d'Ambrosio L; Wentzensen N; Sherman ME
    Cancer Causes Control; 2015 Dec; 26(12):1729-36. PubMed ID: 26376893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic Genomic Events in Endometriosis: Review of the Literature and Approach to Phenotyping.
    Yong PJ; Talhouk A; Anglesio MS
    Reprod Sci; 2021 Oct; 28(10):2743-2757. PubMed ID: 33469880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.
    Khani F; Wobker SE; Hicks JL; Robinson BD; Barbieri CE; De Marzo AM; Epstein JI; Pritchard CC; Lotan TL
    J Pathol; 2019 Sep; 249(1):79-89. PubMed ID: 30993692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study.
    Govatati S; Kodati VL; Deenadayal M; Chakravarty B; Shivaji S; Bhanoori M
    Hum Reprod; 2014 Feb; 29(2):324-36. PubMed ID: 24154570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer.
    Malentacchi F; Turrini I; Sorbi F; Projetto E; Castiglione F; Fambrini M; Petraglia F; Pillozzi S; Noci I
    Oncol Rep; 2019 Mar; 41(3):1560-1574. PubMed ID: 30569174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.
    Pappa KI; Choleza M; Markaki S; Giannikaki E; Kyroudi A; Vlachos G; Voulgaris Z; Anagnou NP
    Gynecol Oncol; 2006 Mar; 100(3):596-600. PubMed ID: 16256179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
    Le Gallo M; Rudd ML; Urick ME; Hansen NF; Zhang S; ; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW
    Cancer; 2017 Sep; 123(17):3261-3268. PubMed ID: 28485815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues.
    Mutter GL; Monte NM; Neuberg D; Ferenczy A; Eng C
    Cancer Res; 2014 May; 74(10):2796-802. PubMed ID: 24662919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTEN mutations as predictive marker for the high-grade endometrial cancer development in slovak women.
    Gbelcová H; Gergely L; Šišovský V; Straka Ľ; Böhmer D; Pastoráková A; Sušienková K; Repiská V; Korbeľ M; Danihel Ľ; Priščáková P
    Physiol Res; 2022 Dec; 71(Suppl 1):S125-S135. PubMed ID: 36592448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression.
    Feng YZ; Shiozawa T; Miyamoto T; Kashima H; Kurai M; Suzuki A; Konishi I
    Clin Cancer Res; 2005 Sep; 11(17):6133-8. PubMed ID: 16144912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer.
    Multinu F; Chen J; Madison JD; Torres M; Casarin J; Visscher D; Shridhar V; Bakkum-Gamez J; Sherman M; Wentzensen N; Mariani A; Walther-Antonio M
    Gynecol Oncol; 2020 Mar; 156(3):682-688. PubMed ID: 31902687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted next-generation sequencing for the detection of cancer-associated somatic mutations in adenomyosis.
    Chao A; Wu RC; Lin CY; Lee LY; Tsai CL; Lee YS; Wang CJ
    J Obstet Gynaecol; 2023 Dec; 43(1):2161352. PubMed ID: 36708516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
    Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
    J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular identification of latent precancers in histologically normal endometrium.
    Mutter GL; Ince TA; Baak JP; Kust GA; Zhou XP; Eng C
    Cancer Res; 2001 Jun; 61(11):4311-4. PubMed ID: 11389050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis.
    Zou Y; Zhou JY; Guo JB; Wang LQ; Luo Y; Zhang ZY; Liu FY; Tan J; Wang F; Huang OP
    Mutat Res; 2018 May; 809():1-5. PubMed ID: 29547736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [KRAS mutations analysis in mucinous epithelial lesions of the endometrium].
    Zheng XZ; Zhan Y; Ma JH; Xu HW; Zhi WX; Chen TB; Qin XY; Wang P; Zhang LH; Gu YC; Jin YL; Zhu L; Wu BQ
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):687-690. PubMed ID: 30220122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.